Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Malvy, Denis ^a,b   Ezzedine, Khaled ^a,b   Mamani Matsuda, Maria ^b   Autran, Brigitte ^c   Tolou, Hugues ^d   Receveur, Marie Catherine ^a,b   Pistone, Thierry ^a,b   Rambert, Jérome ^b   Moynet, Daniel ^b   Mossalayi, Djavad ^a,b  

^a University Hospital Center   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INSERM   (France)

^d SERVICE DE SANTÉ DES ARMÉES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; C REACTIVE PROTEIN; CHEMOKINE; CXCL14 CHEMOKINE; CXCL2 CHEMOKINE; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 22; MESSENGER RNA; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADULT; ARTHRITIS; ARTICLE; BONE RADIOGRAPHY; BONE SCINTISCANNING; CASE REPORT; CHIKUNGUNYA ALPHAVIRUS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE EXPRESSION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNOLOGICAL MONITORING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEROLOGY; VIRUS INFECTION; ALPHAVIRUS INFECTION; BLOOD; IMMUNOLOGY; INFECTIOUS ARTHRITIS; MIDDLE AGED;

ALPHAVIRUS INFECTIONS; ANTIBODIES, VIRAL; ARTHRITIS, INFECTIOUS; CHIKUNGUNYA VIRUS; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED;

EID: 74049099097     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-200     Document Type: Article

References (32)

1. Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, et al. Characterisation of reemerging Chikungunya virus. PLoS Pathog 2007, 3:e89. 10.1371/journal.ppat.0030089, 1904475, 17604450.
2. Ozden S, Huerre M, Riviere JP, Coffey LL, Afonso PV, Mouly V, et al. Human muscle satellite cells as targets of Chikungunya virus. PLoS ONE 2007, 6:e527.
3. Mason PJ, Haddow AJ. An epidemic of virus disease in southern province, Tanganyika territory in 53; an additional note on chikungunya virus isolations and serum antibodies. Trans R Soc Trop Med Hyg 1952, 51:238-40.
4. Enserink M. Infectious diseases. Massive outbreak draws fresh attention to little known virus. Science 2006, 311:1085. 10.1126/science.311.5764.1085a, 16497896.
5. Gratz NG. Emerging and resurging vector-borne diseases. Ann Rev Entomol 1999, 44:51-75.
6. Sissoko D, Moendandze A, Malvy D, Giry C, Ezzedine K, Solet J-L, Pierre V. Seroprevalence and risk factors of chikungunya virus infection in Mayotte, Indian Ocean, 2005-2006: a population-based survey. PLoS ONE 2008, 3:e3066. 10.1371/journal.pone.0003066, 2518850, 18725980.
7. Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, Pierre V. Post-Epidemic Chikungunya Disease on Reunion Island: Course of Rheumatic Manifestations and Associated Factors over a 15-Month Period. PLoS Neglect Trop Dis 2009, 3:e389.
8. Lokireddy S, Vemula S, Vadde R. Connective tissue metabolism in Chikungunya patients. Virol J 2008, 5:31. 10.1186/1743-422X-5-31, 2291039, 18302795.
9. Brighton SW, Simson IW. A destructive arthropathy following chikungunya virus arthritis - a possible association. Clin Rheumatol 1984, 3:253-8. 10.1007/BF02030766, 6088159.
10. Pastorino B, Bessaud M, Grandadam M, Murri S, Tolou HJ, Peyrefitte CN. Development of a TaqMan RT-PCR assay without RNA extraction step for the detection and quantification of African chikungunya viruses. J Virol Methods 2005, 124:65-71. 10.1016/j.jviromet.2004.11.002, 15664052.
11. Fourie ED, Morrison JG. Rheumatoid arthritic syndrome after chikungunya fever. S Afr Med J 1979, 56:130-2.
12. Kennedy AC, Fleming J, Solomon L. Chikungunya viral arthropathy: a clinical description. J Rheumatol 1980, 7:231-6.
13. Simon F, Parola P, Grandadam M, Fourcade S, Oliver M, Brouqui P, Hance P, Kraemer P, Ali Mohamed A, de Lamballerie X, Charrel R, Tolou H. Chikungunya infection. An emerging rheumatism among travellers returned from the Indian Ocean Islands. Medicine 2007, 86:123-37. 10.1097/MD/0b013e31806010a5, 17505252.
14. Couderc T, Chrétien F, Schilte C, Disson O, Madly B, Benhassine-Guivel F, Touret Y, Barau G, Cayet N, Schuffenecker I, Desprès P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M. A mouse model for chikungunya: young age and inefficient type-1 interferon signaling are risk factors for severe disease. PLoS Pathog 2008, 4:e29. 10.1371/journal.ppat.0040029, 2242832,2242832, 18282093.
15. Ryman KD, Klimstra WB, Nguyen KB, Biron CA, Johnston RE. Alpha/beta interferon protects adult mice from fatal Sindbies virus infection and is an important determinant of cell and tissue tropism. J Virol 2000, 74:3066-78.
16. Suhrbier A, La Linn M. Clinical and pathologic aspects of arthritis due to Ross River and other alphaviruses. Curr Opin Rheumatol 2004, 16:374-9. 10.1097/01.bor.0000130537.76808.26, 15201600.
17. Morrisson TE, Whitmore AC, Shabman RS, Lidbury BA, Mahalingam S, Heise MT. Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol 2006, 80:737-49. 10.1128/JVI.80.2.737-749.2006, 1346871, 16378976.
18. Lidbury BA, Rulli NE, Suhrbier A, Smith PN, McColl SR, Cunningham AL, Tarkowski A, van Rooijen N, Fraser RJ, Mahalingam S. Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis 2008, 197:1585-93. 10.1086/587841, 18433328.
19. Grivard P, Le Roux K, Laurent P, Fianu A, Perrau J, Gigan J, Hoarau G, Grondin N, Staikowsky F, Favier F, Michault A. Molecular and serological diagnosis of Chikungunya virus infection. Pathol Biol (Paris) 2007, 55:490-4.
20. Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, Michault A, Arvin-Berod C, Paganin F. Persistent arthralgia associated with Chikungunya virus: a study of 88 adults patients on Reunion Island. Clin Infect Dis 2008, 47:469-79. 10.1086/590003, 18611153.
21. Khan MA, Matthieu A, Sorrentino R, Akkoc N. The pathogenetic role of HLA-B27 and its subtypes. Autoimmunity Rev 2007, 6:183-9.
22. Cohen A, Schoenfeld Y. The viral autoimmunity relationship. Viral Immunol 1995, 8:1-9. 10.1089/vim.1995.8.1, 8546799.
23. Schoenfeld Y. Common infections, idiotypic dysregulation, autoantibodies spread and induction of autoimmune diseases. J Autoimmun 1996, 9:235-9. 10.1006/jaut.1996.0029, 8738968.
24. Fiorillo MT, Ruckert C, Huhsmeyer M, Sorrentino R, Saenger W, Ziegler A, Uchanska-Ziegler B. Allelle-dependant similarity between viral and self-peptide presentation by HLA-B27 subtypes. J Biol Chem 2005, 280:2962-71. 10.1074/jbc.M410807200, 15537660.
25. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004, 22:891-928. 10.1146/annurev.immunol.22.012703.104543, 15032599.
26. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-147.
27. Takeuchi O, Akira S. Recognition of viruses by innate immunity. Immunol Rev 2007, 220:214-24. 10.1111/j.1600-065X.2007.00562.x, 17979849.
28. Honda K, Takaoda A, Taniguchi T. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006, 25:349-60. 10.1016/j.immuni.2006.08.009, 16979567.
29. Stetson DB, Medzhitov R. Type I interferons in host defense. Immunity 2006, 25:373-81. 10.1016/j.immuni.2006.08.007, 16979569.
30. Lin SC, Shyur SD, Ma YC, Huang LH, Lee WI. Hyper-IgM1 syndrome with interstitial pneumonia and diarrhaea caused by coxsackie virus B4 in a 3-month-old infant. Ann Allergy Asthma Immunol 2005, 95:93-7.
31. Qiao X, He B, Shin A, Knowles DN, Chadburn A, Cerruti A. Human immunodeficiency virus 1 Nef suppresses CD40-dependant immunoglobulin class switching in bystander B-cells. Nat Immunol 2006, 7:302-10. 10.1038/ni1302, 16429138.
32. Sitati E, McCandless EE, Klein RS, Diamond MS. CD40-ligand interactions promote trafficking of CD8+ T-cells into the brain and protection against West Nile encephalitis. J Virol 2007, 81:9801-11. 10.1128/JVI.00941-07, 2045405, 17626103.